Current Approaches to the Correction of Hemostasis in Surgeries for Giant Uterine Myoma

Authors

  • O.O. Tarabrin Odessa National Medical University, Odessa
  • D.H. Havrychenko Odessa National Medical University, Odessa
  • S.S. Shcherbakov Odessa National Medical University, Odessa
  • H.I. Mazurenko Odessa National Medical University, Odessa
  • O.V. Turenko Odessa National Medical University, Odessa
  • K.P. Kirpichnikova Odessa National Medical University, Odessa

DOI:

https://doi.org/10.22141/2224-0586.8.71.2015.79203

Keywords:

giant uterine myoma, blood loss, fibrinolysis

Abstract

The objective of the study was to reduce the perioperative blood loss in patients with giant uterine myoma. As a result of studies, we have obtained evidence that the use of antifibrinolytic therapy as intravenous infusion of tranexamic acid 30 minutes before the surgery in a dose of 20 mg/kg followed by infusion of 5 mg/kg per hour for the first postoperative day helped to reduce perioperative blood loss by 29 %. In patients of the second group, hemoglobin level on the second postoperative day was higher by 10 % (p < 0.05), blood loss was lower by 29 % (p < 0.05), the length of stay in hospital was reduced by 24 % (p < 0.05).

Downloads

Download data is not yet available.

Published

2015-12-14

How to Cite

Tarabrin, O., Havrychenko, D., Shcherbakov, S., Mazurenko, H., Turenko, O., & Kirpichnikova, K. (2015). Current Approaches to the Correction of Hemostasis in Surgeries for Giant Uterine Myoma. EMERGENCY MEDICINE, (8.71), 87–91. https://doi.org/10.22141/2224-0586.8.71.2015.79203

Issue

Section

Original Researches